Mefruside

Mefruside
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code C03BA05 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 7195-27-9 YesY
PubChem (CID) 4047
ChemSpider 3907 N
UNII X1NS9SNS92 YesY
KEGG D01877 YesY
ECHA InfoCard 100.027.785
Chemical and physical data
Formula C13H19ClN2O5S2
Molar mass 382.88 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

  1. Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.


This article is issued from Wikipedia - version of the 5/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.